Wellgistics Health Expands with AI and Public Transition

Wellgistics Health Inc ( (WGRX) ) just unveiled an announcement.

On March 21, 2025, Wellgistics Health, Inc. granted over 19 million shares of restricted stock under its 2023 Equity Incentive Plan to directors, employees, and consultants, with varying vesting schedules. This move is part of the company’s broader strategy to enhance its market position and operational efficiency. Additionally, Wellgistics Health has transitioned from a private to a public company, expanded its service offerings through acquisitions, and reported a 33% increase in net sales for 2024. The company has developed an AI-enhanced prescription processing platform and launched EinsteinRx to improve prescription routing and affordability. These initiatives aim to address systemic issues in the pharmaceutical supply chain, such as pricing transparency and prescription adherence, positioning Wellgistics Health as a key player in the evolving healthcare market.

More about Wellgistics Health Inc

Wellgistics Health, Inc. is a holding company focused on healthcare technology and pharmaceutical services, aiming to create a micro health ecosystem. It offers a portfolio of technology platforms, pharmacy, and wholesale operations that provide prescription hub and clinical services. The company is dedicated to improving patient lives and offering solutions for pharmacies, providers, pharmaceutical manufacturers, and payors, with a focus on patient-centric pharmaceutical care.

YTD Price Performance: 3.67%

Average Trading Volume: 184,314

Find detailed analytics on WGRX stock on TipRanks’ Stock Analysis page.